MSB 3163
Alternative Names: MSB-3163Latest Information Update: 06 Jan 2023
At a glance
- Originator University of California, San Diego
- Developer MatriSys Bio
- Class Antiacnes; Bacteria
- Mechanism of Action Bacteria replacements; Microbiome modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I Acne